Financial Network Wealth Advisors LLC
Position in RDY — Dr Reddys Laboratories Ltd
CIK 2012031
MURRAY, UT
Position in RDY
as of Jun 30, 2026
· filed Jul 29, 2026
Position Value
$854
New position
Shares Held
59
first reported quarter
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#233
of 238 holders
Holding Since
Jun 2026
1 quarter on record
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Financial Network Wealth Advisors LLC holds $10,260 across 8 Drug Manufacturers - Specialty & Generic names. RDY ranks #6 (8.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ZTS |
Zoetis Inc.
|
38 | $2,730 | |
| 2 | VTRS |
Viatris Inc
|
96 | $1,524 | |
| 3 | HLN |
Haleon plc
|
146 | $1,362 | |
| 4 | TAK |
Takeda Pharmaceutical Co Ltd
|
74 | $1,186 | |
| 5 | INCR |
Intercure Ltd.
|
200 | $1,100 | |
| 6 | RDY |
Dr Reddys Laboratories Ltd
This page
|
59 | $854 | |
| 7 | AMRX |
Amneal Pharmaceuticals, Inc.
|
48 | $830 | |
| 8 | NBIX |
Neurocrine Biosciences Inc
|
4 | $674 |
All Filings in RDY
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $854 | 59 | Shares | Sole | 2026-07-29 | |
| No filing history on record for this holder in this stock. | ||||||